Clinical Trials Browser

Phase 2/3 × Celecoxib × Dermatologic × Clear all

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic